BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget. 2015;6:18613-18630. [PMID: 26164082 DOI: 10.18632/oncotarget.4317] [Cited by in Crossref: 44] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Gungor MZ, Uysal M, Senturk S. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. Cancers (Basel) 2022;14:940. [PMID: 35205692 DOI: 10.3390/cancers14040940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhang Y, Shao J, Li S, Liu Y, Zheng M. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma. Front Oncol 2021;11:775250. [PMID: 34804980 DOI: 10.3389/fonc.2021.775250] [Reference Citation Analysis]
3 Min Z, Xunlei Z, Haizhen C, Wenjing Z, Haiyan Y, Xiaoyun L, Jianyun Z, Xudong C, Aiguo S. The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis. Front Bioinform 2021;1:706835. [DOI: 10.3389/fbinf.2021.706835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Juaid N, Amin A, Abdalla A, Reese K, Alamri Z, Moulay M, Abdu S, Miled N. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. Int J Mol Sci 2021;22:10774. [PMID: 34639131 DOI: 10.3390/ijms221910774] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
5 Kang B, Qiu C, Zhang Y. The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890. J Healthc Eng 2021;2021:1643788. [PMID: 34306585 DOI: 10.1155/2021/1643788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Fan B, Jin X, Ding Q, Cao C, Shi Y, Zhu H, Zhou W. Expression of miR-451a in Prostate Cancer and Its Effect on Prognosis. Iran J Public Health 2021;50:772-9. [PMID: 34183927 DOI: 10.18502/ijph.v50i4.6002] [Reference Citation Analysis]
7 Zhang MF, Fei ZW, Huang L. Micro-RNA-451 Reduces Proliferation of B-CPAP Human Papillary Thyroid Cancer Cells by Downregulating Expression of Activating Transcription Factor 2. Med Sci Monit 2021;27:e929774. [PMID: 33724979 DOI: 10.12659/MSM.929774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu XY, Wang JQ, Ashby CR Jr, Zeng L, Fan YF, Chen ZS. Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer. Drug Discov Today 2021;26:1284-92. [PMID: 33549529 DOI: 10.1016/j.drudis.2021.01.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
9 Cui J, Wang J, Shen Y, Lin D. Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC. Genes Genomics 2021;43:105-14. [PMID: 33460027 DOI: 10.1007/s13258-020-01028-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Xu Y, Lai Y, Cao L, Li Y, Chen G, Chen L, Weng H, Chen T, Wang L, Ye Y. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10. RNA Biol 2020;:1-16. [PMID: 33206588 DOI: 10.1080/15476286.2020.1851540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhong L, Xu Z, Jin X, He Y, Zhang J, Jiang T, Chen J. miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma. Oncol Lett 2020;20:339. [PMID: 33123250 DOI: 10.3892/ol.2020.12202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhong L, Jin X, Xu Z, Zeng M, Chen D, He Y, Zhang J, Jiang T, Chen J. Circulating miR-451a levels as a potential biomarker to predict the prognosis of patients with multiple myeloma. Oncol Lett 2020;20:263. [PMID: 32989397 DOI: 10.3892/ol.2020.12126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ríos-lópez DG, Aranda-lópez Y, Sosa-garrocho M, Macías-silva M. La plasticidad del hepatocito y su relevancia en la fisiología y la patología hepática. TIP RECQB 2020;23. [DOI: 10.22201/fesz.23958723e.2020.0.225] [Reference Citation Analysis]
14 Qin X, Song Y. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma. Med Sci Monit 2020;26:e921815. [PMID: 32435051 DOI: 10.12659/MSM.921815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang T, Zhou Q, Shang Y. MiRNA-451a inhibits airway remodeling by targeting Cadherin 11 in an allergic asthma model of neonatal mice. Int Immunopharmacol 2020;83:106440. [PMID: 32234673 DOI: 10.1016/j.intimp.2020.106440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Giannelli G, Santoro A, Kelley RK, Gane E, Paradis V, Cleverly A, Smith C, Estrem ST, Man M, Wang S, Lahn MM, Raymond E, Benhadji KA, Faivre S. Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS One 2020;15:e0222259. [PMID: 32210440 DOI: 10.1371/journal.pone.0222259] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
17 Omran NM, El-Sherbini SM, Hegazy O, Elshaarawy AA, Talaat RM. Crosstalk between miR-215 and epithelial-mesenchymal transition specific markers (E-cadherin and N-cadherin) in different stages of chronic HCV Infection. J Med Virol 2020;92:1231-8. [PMID: 31769519 DOI: 10.1002/jmv.25637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Bai H, Wu S. miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer. Onco Targets Ther 2019;12:11069-82. [PMID: 31908476 DOI: 10.2147/OTT.S230963] [Cited by in Crossref: 23] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
19 Fornari F, Gramantieri L, Callegari E, Shankaraiah RC, Piscaglia F, Negrini M, Giovannini C. MicroRNAs in Animal Models of HCC. Cancers (Basel) 2019;11:E1906. [PMID: 31805631 DOI: 10.3390/cancers11121906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kong W, Feng L, Yang M, Chen Q, Wang H, Wang X, Hou J. Prognostic value of microRNA-451 in various cancers: A meta-analysis. Pathol Res Pract 2019;215:152726. [PMID: 31708373 DOI: 10.1016/j.prp.2019.152726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Fan X, Jin S, Li Y, Khadaroo PA, Dai Y, He L, Zhou D, Lin H. Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma. Cancer Manag Res 2019;11:8947-63. [PMID: 31802937 DOI: 10.2147/CMAR.S225606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
22 Khordadmehr M, Jigari-Asl F, Ezzati H, Shahbazi R, Sadreddini S, Safaei S, Baradaran B. A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential. J Cell Physiol 2019;234:21716-31. [PMID: 31140618 DOI: 10.1002/jcp.28888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ogawa D, Ansari K, Nowicki MO, Salińska E, Bronisz A, Godlewski J. MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy. Noncoding RNA 2019;5:E25. [PMID: 30875963 DOI: 10.3390/ncrna5010025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
24 Mamoori A, Wahab R, Vider J, Gopalan V, Lam AK. The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer. Gene 2019;697:165-74. [PMID: 30802541 DOI: 10.1016/j.gene.2019.02.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
25 Xu K, Han B, Bai Y, Ma XY, Ji ZN, Xiong Y, Miao SK, Zhang YY, Zhou LM. MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer. Cell Death Dis 2019;10:152. [PMID: 30770794 DOI: 10.1038/s41419-019-1403-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 40] [Article Influence: 8.7] [Reference Citation Analysis]
26 Pomatto MAC, Bussolati B, D'Antico S, Ghiotto S, Tetta C, Brizzi MF, Camussi G. Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs. Mol Ther Methods Clin Dev. 2019;13:133-144. [PMID: 30788382 DOI: 10.1016/j.omtm.2019.01.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 94] [Article Influence: 21.3] [Reference Citation Analysis]
27 Shao Y, Dong LJ, Takahashi Y, Chen J, Liu X, Chen Q, Ma JX, Li XR. miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy. Am J Physiol Endocrinol Metab 2019;316:E443-52. [PMID: 30576241 DOI: 10.1152/ajpendo.00360.2018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
28 Sun H, Jiang P. MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma. Mol Genet Genomic Med 2018;6:1001-9. [PMID: 30209892 DOI: 10.1002/mgg3.473] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
29 Lin H, Huang ZP, Liu J, Qiu Y, Tao YP, Wang MC, Yao H, Hou KZ, Gu FM, Xu XF. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN. Sci Rep 2018;8:10461. [PMID: 29992971 DOI: 10.1038/s41598-018-28519-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
30 Nie X, Liu Y, Chen WD, Wang YD. Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma. Front Pharmacol 2018;9:657. [PMID: 29977206 DOI: 10.3389/fphar.2018.00657] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
31 Chen E, Xu X, Liu R, Liu T. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. Biomed Res Int 2018;2018:6784607. [PMID: 29951542 DOI: 10.1155/2018/6784607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li S, Yao J, Xie M, Liu Y, Zheng M. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol 2018;11:54. [PMID: 29642941 DOI: 10.1186/s13045-018-0579-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
33 Zu C, Liu S, Cao W, Liu Z, Qiang H, Li Y, Cheng C, Ji L, Li J, Li J. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression. Oncotarget 2017;8:34698-708. [PMID: 28423728 DOI: 10.18632/oncotarget.16150] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
34 Li L, Gao R, Yu Y, Kaul Z, Wang J, Kalra RS, Zhang Z, Kaul SC, Wadhwa R. Tumor suppressor activity of miR-451: Identification of CARF as a new target. Sci Rep 2018;8:375. [PMID: 29321561 DOI: 10.1038/s41598-017-18559-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
35 Li C, Qin F, Hu F, Xu H, Sun G, Han G, Wang T, Guo M. Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles. Cell Biosci 2018;8:2. [PMID: 29344346 DOI: 10.1186/s13578-018-0202-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
36 Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Oncotarget 2016;7:22674-86. [PMID: 26993767 DOI: 10.18632/oncotarget.8047] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
37 Minna E, Romeo P, Dugo M, De Cecco L, Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, Greco A, Borrello MG. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Oncotarget 2016;7:12731-47. [PMID: 26871295 DOI: 10.18632/oncotarget.7262] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 11.0] [Reference Citation Analysis]
38 Zhang Y, Wei C, Guo CC, Bi RX, Xie J, Guan DH, Yang CH, Jiang YH. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis. Oncotarget 2017;8:107237-57. [PMID: 29291025 DOI: 10.18632/oncotarget.20883] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
39 Ge S, Xu Y, Wang H, Sun Y, Tian X, Cao Z, Lin X, Xu J, Wang Q. Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma. Oncol Lett 2017;14:3689-96. [PMID: 28927132 DOI: 10.3892/ol.2017.6616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
40 He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX. Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. Onco Targets Ther 2017;10:3435-51. [PMID: 28744148 DOI: 10.2147/OTT.S139546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
41 Lee AF, Chen MC, Chen CJ, Yang CJ, Huang MS, Liu YP. Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells. PLoS One 2017;12:e0180383. [PMID: 28683123 DOI: 10.1371/journal.pone.0180383] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
42 Zhang M, Wu W, Gao M, Fei Z. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma. CBM 2017;19:437-45. [DOI: 10.3233/cbm-170059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
43 Della Corte CM, Viscardi G, Papaccio F, Esposito G, Martini G, Ciardiello D, Martinelli E, Ciardiello F, Morgillo F. Implication of the Hedgehog pathway in hepatocellular carcinoma. World J Gastroenterol 2017; 23(24): 4330-4340 [PMID: 28706416 DOI: 10.3748/wjg.v23.i24.4330] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
44 Zhang P, Tang WM, Zhang H, Li YQ, Peng Y, Wang J, Liu GN, Huang XT, Zhao JJ, Li G, Li AM, Bai Y, Chen Y, Ren YX, Li GX, Wang YD, Liu SD, Wang JD. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Br J Cancer 2017;117:525-34. [PMID: 28632723 DOI: 10.1038/bjc.2017.181] [Cited by in Crossref: 47] [Cited by in F6Publishing: 60] [Article Influence: 9.4] [Reference Citation Analysis]
45 Xu K, Zhang Y, Han B, Bai Y, Xiong Y, Song Y, Zhou L. Suppression subtractive hybridization identified differentially expressed genes in colorectal cancer: microRNA-451a as a novel colorectal cancer–related gene. Tumour Biol 2017;39:101042831770550. [DOI: 10.1177/1010428317705504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
46 Qin X, Chen J, Wu L, Liu Z. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma. Biomed Pharmacother 2017;89:742-50. [PMID: 28273636 DOI: 10.1016/j.biopha.2017.02.062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
47 Kwekel JC, Vijay V, Han T, Moland CL, Desai VG, Fuscoe JC. Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biol Sex Differ 2017;8:6. [PMID: 28174625 DOI: 10.1186/s13293-017-0127-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
48 Chen Y, Li L, Qian X, Ge Y, Xu G. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2017;41:190-6. [PMID: 28065743 DOI: 10.1016/j.clinre.2016.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
49 Tu K, Zhao L, Gu J, Yan P, Wang F, Cao Y. The function of activatable cell-penetrating peptides in human intrahepatic bile duct epithelial cells. J Bioenerg Biomembr 2016;48:599-606. [PMID: 27889841 DOI: 10.1007/s10863-016-9690-8] [Reference Citation Analysis]
50 Liu SY, Deng SY, He YB, Ni GX. miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R. Biochem Biophys Res Commun 2017;482:987-93. [PMID: 27908732 DOI: 10.1016/j.bbrc.2016.11.145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
51 Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget 2015;6:40920-33. [PMID: 26506518 DOI: 10.18632/oncotarget.5712] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
52 Witwer KW, Halushka MK. Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research. RNA Biol 2016;13:1103-16. [PMID: 27645402 DOI: 10.1080/15476286.2016.1236172] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 13.7] [Reference Citation Analysis]
53 Khan FS, Ali I, Afridi UK, Ishtiaq M, Mehmood R. Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics. Hepatol Int 2017;11:45-53. [PMID: 27271356 DOI: 10.1007/s12072-016-9743-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
54 Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798-808. [PMID: 27212245 DOI: 10.1016/j.jhep.2016.05.007] [Cited by in Crossref: 209] [Cited by in F6Publishing: 285] [Article Influence: 34.8] [Reference Citation Analysis]
55 El-Gewely MR, Andreassen M, Walquist M, Ursvik A, Knutsen E, Nystad M, Coucheron DH, Myrmel KS, Hennig R, Johansen SD. Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors. Cancers (Basel) 2016;8:E31. [PMID: 26950155 DOI: 10.3390/cancers8030031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
56 Huan L, Liang LH, He XH. Role of microRNAs in inflammation-associated liver cancer. Cancer Biol Med 2016;13:407-25. [PMID: 28154773 DOI: 10.20892/j.issn.2095-3941.2016.0071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]